News Headline Summary

EU says Johnson & Johnson (JNJ) and Novartis (NOVN VX) contracts delayed generic drugs

- Co.'s get EU antitrust objections.
- EU probings JNJ and NOVN VX contracts over Fentanyl painkiller.

Reaction details (10:49)

- Novartis shares are unmoved in reaction to the news; trades CHF 61.90 (-0.40%) last.

31 Jan 2013 - 10:45 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: